What type of cancer is Li-Fraumeni syndrome (Sarcoma, Adrenal cancer, Leukaemia (Leukemia) & Breast cancer) associated with?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Li-Fraumeni Syndrome Cancer Associations

Li-Fraumeni syndrome is associated with breast cancer, not colon, ovarian, or lung cancer. The core cancers in Li-Fraumeni syndrome include soft tissue sarcomas, osteosarcomas, premenopausal breast cancer, brain tumors, and adrenocortical carcinoma. 1

Core Cancers Associated with Li-Fraumeni Syndrome

Li-Fraumeni syndrome (LFS) is a rare hereditary cancer predisposition syndrome caused by germline mutations in the TP53 tumor suppressor gene. The syndrome is characterized by a specific pattern of malignancies:

  • Soft tissue sarcomas - One of the most common cancers in LFS 1
  • Osteosarcomas - Bone tumors that typically present at younger ages 1
  • Premenopausal breast cancer - Particularly early-onset breast cancer 1
  • Brain tumors - Including gliomas, choroid plexus carcinomas, and SHH subtype medulloblastomas 1
  • Adrenocortical carcinoma - Rare cancer of the adrenal cortex 1
  • Leukemia - Hematologic malignancies, including hypodiploid acute lymphoblastic leukemia 1

Cancer Risk and Penetrance

The cancer risk in individuals with Li-Fraumeni syndrome is extremely high:

  • Nearly 100% lifetime cumulative cancer incidence 1
  • By age 70, women have a 54% risk of breast cancer, 15% risk of soft tissue sarcoma, 6% risk of brain cancer, and 5% risk of osteosarcoma 1
  • Men have a 22% risk of soft tissue sarcoma, 19% risk of brain cancer, and 11% risk of osteosarcoma by age 70 1
  • Multiple primary cancers are common in affected individuals 1, 2

Additional Associated Cancers

Beyond the core cancers, LFS is also associated with:

  • Gastric cancer 1, 3
  • Colon cancer 1
  • Bronchoalveolar cancer 1
  • Thyroid cancer 3
  • Melanoma (suggested by case reports) 1

Clinical Implications

Understanding the cancer spectrum in LFS is critical for several reasons:

  • Early diagnosis allows for appropriate surveillance protocols 1
  • Radiation exposure should be minimized due to increased risk of radiation-induced secondary malignancies 2
  • Breast cancer management differs from standard protocols, often favoring total mastectomy over lumpectomy with radiation 3
  • Screening should include whole-body MRI and other targeted imaging to detect cancers early 4, 3

Genetic Basis

  • LFS is caused by germline mutations in the TP53 gene, located on chromosome 17 5
  • The p53 protein functions as the "guardian of the genome" by controlling cell cycle and apoptosis 5
  • Germline mutations in TP53 are found in over 50% of families meeting classic LFS criteria 1
  • The type of TP53 mutation may influence disease penetrance and cancer spectrum 5

In summary, breast cancer is one of the core cancers associated with Li-Fraumeni syndrome, making option D the correct answer. Colon cancer can occur in LFS but is not considered a core cancer. Ovarian and lung cancers are not among the primary cancers associated with this syndrome.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Li-Fraumeni Syndrome: Imaging Features and Guidelines.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2024

Research

Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.

International journal of clinical oncology, 2021

Guideline

Li-Fraumeni Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.